Alliance Generic Drug & Alcohol Prescribing Service

Opportunity overview

PIN Notice 162228 was published on 27/02/2026, the Contract Title has been amended from The Provision of Drug & Alcohol Prescribing - Criminal Justice Services to Alliance Generic Drug & Alcohol Prescribing Service. The Health Board is commissioning an interim clinical drug and alcohol treatment service to support adults in Swansea and Neath Port Talbot who require prescribing interventions, including those within the criminal justice system. The service will deliver safe, evidence‑based opioid substitution therapy and alcohol treatment, with rapid clinical assessment and a strong emphasis on same‑day or timely prescribing to minimise risk and improve engagement. It will work as part of the wider Alliance model, integrating seamlessly with psychosocial services and supporting continuity of care from custody, court and prison into the community. The provider will be responsible for maintaining robust clinical governance, ensuring compliance with national guidelines and collaborating closely with criminal justice partners to facilitate effective pathways, reduce harm, and support individuals' recovery goals. Kaleidoscope Project are the only providers in the region that are able to deliver the Contract Requirement. It is the Intention to award the contract to Kaleidoscope Project under the MSPP - Most Suitable Provider Process. The contract will be for a One Year Duration, from 1st April 2026 to 31st March 2027

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Classification

• CPV85140000 — Miscellaneous health services
• CPV85312500 — Rehabilitation services

Lots

• The interim clinical drug and alcohol treatment service will deliver a comprehensive range of prescribing interventions, including stabilisation, reduction, withdrawal, detoxification, relapse prevention, and support towards recovery or abstinence, all in line with UK clinical guidelines and NICE standards. The service is designed for rapid access, aiming for same-day prescribing wherever possible and guaranteeing that waiting times from referral to treatment do not exceed 10 working days, including for those within the criminal justice system. Continuity of care is a priority, ensuring uninterrupted prescribing for individuals released from prison or court, with provision for evening, weekend, and bank holiday coverage. Clinical assessment is mandatory prior to prescribing, and the assessment will follow the individual throughout their recovery journey. The service will support a range of criminal justice pathways, including Drug Testing on Arrest (DToA), Arrest Referral, Drug Rehabilitation Requirement (DRR), Alcohol Treatment Requirement (ATR), and continuity of care following release from prison. Robust clinical governance will be maintained, aligned to Public Health Wales standards, with regular audits, mandatory training, and compliance with all statutory and regulatory frameworks. The provider will work closely with criminal justice partners—such as police, probation, courts, and prison healthcare—to facilitate effective pathways, reduce harm, and support recovery goals. Performance standards include minimum KPIs of prescribing within 10 working days, same-day opioid substitution therapy (OST) availability, and seamless continuity of care for individuals released from prison. The service will exclude individuals with significant unmanaged physical or mental health needs, pregnant women, and those over 80 years old, as these cases will be managed within Community Drug and Alcohol Team (CDAT) services. The service must be provided within the Swansea Bay Footprint. Currently there is only one specialist provider that are able to deliver the Health Boards requirement, namely Kaleidoscope Project. This will be awarded following the Most Suitable Provider Process. The contract will be for a One Year Duration, from 1st April 2026 to 31st March 2027 Additional information: The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 25/03/2026 E-mail: nicola.craven@wales.nhs.uk. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR Wales.Value not stated